Memphasys Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
180.90
84.40
212.70
61.70
3,865.20
244.60
Total Accounts Receivable
1,381.30
720.10
355.00
796.20
484.30
592.70
Inventories
400.40
300.20
12.40
-
-
-
Other Current Assets
125.70
52.90
513.00
38.70
44.20
24
Total Current Assets
2,088.30
1,157.70
1,093.10
896.60
4,393.70
861.30
Net Property, Plant & Equipment
6,827.30
425.30
67.60
62.00
41.30
22.70
Total Investments and Advances
300.00
4,124.90
3,824.90
3,824.90
-
-
Intangible Assets
3,885.10
1,670.60
1,970.60
2,483.10
2,956.30
3,333.20
Other Assets
531.30
-
-
-
-
-
Total Assets
13,632.00
7,378.50
6,956.20
7,266.60
7,391.30
4,217.20
ST Debt & Current Portion LT Debt
479.30
479.70
2,585.80
4,843.50
5,718.60
Accounts Payable
1,848.50
627.10
245.20
430.20
334.70
Income Tax Payable
139.40
270.40
104.40
50.60
86.80
Other Current Liabilities
1,200.90
685.80
436.50
395.80
610.20
Total Current Liabilities
3,668.10
2,063.00
3,371.90
5,720.00
6,750.40
Long-Term Debt
1,568.30
6,236.80
2,785.50
43.00
1,020.90
Provision for Risks & Charges
1,405.50
71.50
52.30
25.90
22.20
Total Liabilities
6,641.90
8,371.30
6,209.60
5,788.90
7,793.50
Common Equity (Total)
1,822.60
992.80
746.60
1,477.70
402.20
Total Shareholders' Equity
1,822.60
992.80
746.60
1,477.70
402.20
Total Equity
6,990.10
992.80
746.60
1,477.70
402.20
Liabilities & Shareholders' Equity
13,632.00
7,378.50
6,956.20
7,266.60
7,391.30
Accumulated Minority Interest
5,167.50
-
-
-
-

About Memphasys

View Profile
Address
30-32 Richmond Road
Sydney New South Wales (NSW) 2140
Australia
Employees -
Website http://www.memphasys.com.au
Updated 07/08/2019
Memphasys Ltd. is a life sciences company, which is engaged in the development, manufacture and sale of pre-cast electrophoresis gels, separations equipment and consumables, analytical software and other biological products for life science market. It operates through the following segments: Consumable Products, Separations, and Corporate. The Consumable Products segment develops, manufactures and distributes pre-cast electrophoresis gels and other biological products into the marketplace.